Kenvue Inc. reported third quarter 2026 results that exceeded earnings expectations but slightly missed revenue estimates, primarily due to weakness in the flagship Skin Health and Beauty segment. While the company achieved its fourth consecutive quarter of organic sales growth, distribution losses and promotional timing in the U.S. led to segment-specific contraction.
Key Highlights
- Skin Health and Beauty organic sales declined 0.5% as U.S. distribution losses and retailer negotiations in Europe offset growth in Rogaine and OGX hair care products.
- Self Care organic sales increased 5.4%, driven by strong innovation in Pain Care (Motrin) and low double-digit growth in Smoking Cessation (Nicorette).
- Adjusted gross profit margin expanded 30 basis points to 61.5%, benefiting from global supply chain optimization and value realization that outweighed inflationary pressures.
- Free cash flow improved significantly to $1.6 billion for the first nine months of the year, up from $1.0 billion in the prior-year period.